In this multimodal longitudinal [18F]GE-180 PET study we corroborate the translocator protein TSPO as an interesting target for in vivo imaging of glioblastoma, as confirmed by ex vivo autoradiography, in vitro autoradiography and TSPO staining in a preclinical setting. Here, TSPO is linked to glioblastoma.